Laura Allington

University College London Hospitals NHS Foundation Trust

Laura qualified as a Therapeutic Radiographer in 1995 and commenced her career at The Royal Marsden Hospital. Since moving to UCLH in 1999, she has held a number of positions across both the pre-treatment and treatment areas of radiotherapy. For the past 15 years she has played a key role in implementing new treatment techniques and influencing changes in practice within the department. Some of this work formed part of a Masters level degree that she completed in 2016. Since 2015, Laura has been involved in all aspects of developing the NHS UK proton service which has included equipment procurement, patient pathway design, workforce modelling and patient engagement. For the past year, she has held the position of Operational Lead for Proton Beam Therapy at UCLH.

dont miss

Operational challenges of planning a new NHS high energy proton service.

Perspective overview from University College London Hospitals NHS Foundation Trust of implementing the NHS high energy proton therapy service with the Christie NHS Foundation Trust.

EVEN MORE SEMINARS

  • Mr Naga Venkatesh Jayanthi MD, FRCS: Speaking at the Oncology Convention

    Mr Naga Venkatesh Jayanthi MD, FRCS
    Bupa - Consultant Surgeon

    Minimal Invasive Oesophagectomy – where are we going?

  • Michael Schreiber: Speaking at the Oncology Convention

    Michael Schreiber
    Brain Tumor Foundation, Chairman

    Brain Tumors - Innovation, support and advocacy

  • Laura Allington: Speaking at the Oncology Convention

    Laura Allington
    University College London Hospitals NHS Foundation Trust

    Operational challenges of planning a new NHS high energy proton service.

  • Gareth Thomas BDS, MScD, PhD, FDSRCS, FRCPath: Speaking at the Oncology Convention

    Gareth Thomas BDS, MScD, PhD, FDSRCS, FRCPath
    University Hospital Southampton NHS Foundation Trust.

    Targeted therapies: aiming at the tumour micro-environment

  • Glenn Flux: Speaking at the Oncology Convention

    Glenn Flux
    Royal Marsden Hospital

    The emergence and resurgence of radiotherapeutics for cancer treatment